Mellor AL - Search Results

1

Reprogrammed foxp3(+) regulatory T cells provide essential help to support cross-presentation and CD8(+) T cell priming in naive mice.

Sharma MD, Hou DY, Baban B, Koni PA, He Y, Chandler PR, Blazar BR, Mellor AL, Munn DH. Sharma MD, et al. Among authors: mellor al. Immunity. 2010 Dec 14;33(6):942-54. doi: 10.1016/j.immuni.2010.11.022. Epub 2010 Dec 9. Immunity. 2010. PMID: 21145762 Free PMC article.

2

Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses.

Mellor AL, Keskin DB, Johnson T, Chandler P, Munn DH. Mellor AL, et al. J Immunol. 2002 Apr 15;168(8):3771-6. doi: 10.4049/jimmunol.168.8.3771. J Immunol. 2002. PMID: 11937528

3

Ligation of B7-1/B7-2 by human CD4+ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells.

Munn DH, Sharma MD, Mellor AL. Munn DH, et al. Among authors: mellor al. J Immunol. 2004 Apr 1;172(7):4100-10. doi: 10.4049/jimmunol.172.7.4100. J Immunol. 2004. PMID: 15034022

4

Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes.

Munn DH, Sharma MD, Hou D, Baban B, Lee JR, Antonia SJ, Messina JL, Chandler P, Koni PA, Mellor AL. Munn DH, et al. Among authors: mellor al. J Clin Invest. 2004 Jul;114(2):280-90. doi: 10.1172/JCI21583. J Clin Invest. 2004. PMID: 15254595 Free PMC article.

5

Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase.

Mellor AL, Chandler P, Baban B, Hansen AM, Marshall B, Pihkala J, Waldmann H, Cobbold S, Adams E, Munn DH. Mellor AL, et al. Int Immunol. 2004 Oct;16(10):1391-401. doi: 10.1093/intimm/dxh140. Epub 2004 Sep 6. Int Immunol. 2004. PMID: 15351783

6

GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase.

Munn DH, Sharma MD, Baban B, Harding HP, Zhang Y, Ron D, Mellor AL. Munn DH, et al. Among authors: mellor al. Immunity. 2005 May;22(5):633-42. doi: 10.1016/j.immuni.2005.03.013. Immunity. 2005. PMID: 15894280 Free article.

7

Cutting edge: CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN Type 1 signaling.

Mellor AL, Baban B, Chandler PR, Manlapat A, Kahler DJ, Munn DH. Mellor AL, et al. J Immunol. 2005 Nov 1;175(9):5601-5. doi: 10.4049/jimmunol.175.9.5601. J Immunol. 2005. PMID: 16237046

8

Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses.

Hou DY, Muller AJ, Sharma MD, DuHadaway J, Banerjee T, Johnson M, Mellor AL, Prendergast GC, Munn DH. Hou DY, et al. Among authors: mellor al. Cancer Res. 2007 Jan 15;67(2):792-801. doi: 10.1158/0008-5472.CAN-06-2925. Cancer Res. 2007. PMID: 17234791

9

Cell-autonomous control of interferon type I expression by indoleamine 2,3-dioxygenase in regulatory CD19+ dendritic cells.

Manlapat AK, Kahler DJ, Chandler PR, Munn DH, Mellor AL. Manlapat AK, et al. Among authors: mellor al. Eur J Immunol. 2007 Apr;37(4):1064-71. doi: 10.1002/eji.200636690. Eur J Immunol. 2007. PMID: 17343295 Free article.

10

Indoleamine 2,3-dioxygenase and tumor-induced tolerance.

Munn DH, Mellor AL. Munn DH, et al. Among authors: mellor al. J Clin Invest. 2007 May;117(5):1147-54. doi: 10.1172/JCI31178. J Clin Invest. 2007. PMID: 17476344 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

221 results

Search Page

Filters